| Leonard Lev, MD | |
|
19409 Plantation Rd Ste 4, Rehoboth Beach, DE 19971-4413 | |
| (914) 714-8197 | |
| Not Available |
| Full Name | Leonard Lev |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 42 Years |
| Location | 19409 Plantation Rd Ste 4, Rehoboth Beach, Delaware |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033287982 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 037213 (Connecticut) | Secondary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | C10024110 (Delaware) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Beebe Medical Center | Lewes, DE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Beebe Physician Network Inc. | 5496744864 | 208 |
News Archive
Vitamin D deficiency is common and cancer risk is higher among those individuals with low vitamin D levels, according to an analysis of research which will be presented at a symposium by Donald L.
EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, announced today the publication of 10-year outcome data showing that PROSTASCINT(R) (capromab pendetide) fusion imaging is an effective tool for targeting and guiding the dosing of prostate cancer radiotherapy.
Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that the European Commission, acting on the positive recommendation from the European Medicines Agency Committee for Orphan Medicinal Products (COMP), has granted orphan drug designation to synthetic hypericin (the active pharmaceutical ingredient in SGX301) for the treatment of cutaneous T-cell lymphoma (CTCL), a rare disease and a class of non-Hodgkin's lymphoma, a type of cancer of the white blood cells that are an integral part of the immune system.
A team of neurobiologists at the Institut de Neurosciences de la Timone (CNRS/Aix-Marseille Université) has just shown that within a population of rats it can predict which will become cocaine addicts.
› Verified 5 days ago
| Entity Name | Beebe Physician Network Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730133992 PECOS PAC ID: 5496744864 Enrollment ID: O20040511000133 |
News Archive
Vitamin D deficiency is common and cancer risk is higher among those individuals with low vitamin D levels, according to an analysis of research which will be presented at a symposium by Donald L.
EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, announced today the publication of 10-year outcome data showing that PROSTASCINT(R) (capromab pendetide) fusion imaging is an effective tool for targeting and guiding the dosing of prostate cancer radiotherapy.
Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that the European Commission, acting on the positive recommendation from the European Medicines Agency Committee for Orphan Medicinal Products (COMP), has granted orphan drug designation to synthetic hypericin (the active pharmaceutical ingredient in SGX301) for the treatment of cutaneous T-cell lymphoma (CTCL), a rare disease and a class of non-Hodgkin's lymphoma, a type of cancer of the white blood cells that are an integral part of the immune system.
A team of neurobiologists at the Institut de Neurosciences de la Timone (CNRS/Aix-Marseille Université) has just shown that within a population of rats it can predict which will become cocaine addicts.
› Verified 5 days ago
| Entity Name | Thrive Counseling Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215181300 PECOS PAC ID: 0749458420 Enrollment ID: O20210429000005 |
News Archive
Vitamin D deficiency is common and cancer risk is higher among those individuals with low vitamin D levels, according to an analysis of research which will be presented at a symposium by Donald L.
EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, announced today the publication of 10-year outcome data showing that PROSTASCINT(R) (capromab pendetide) fusion imaging is an effective tool for targeting and guiding the dosing of prostate cancer radiotherapy.
Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that the European Commission, acting on the positive recommendation from the European Medicines Agency Committee for Orphan Medicinal Products (COMP), has granted orphan drug designation to synthetic hypericin (the active pharmaceutical ingredient in SGX301) for the treatment of cutaneous T-cell lymphoma (CTCL), a rare disease and a class of non-Hodgkin's lymphoma, a type of cancer of the white blood cells that are an integral part of the immune system.
A team of neurobiologists at the Institut de Neurosciences de la Timone (CNRS/Aix-Marseille Université) has just shown that within a population of rats it can predict which will become cocaine addicts.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Leonard Lev, MD 19409 Plantation Rd Ste 4, Rehoboth Beach, DE 19971-4413 Ph: (914) 714-8197 | Leonard Lev, MD 19409 Plantation Rd Ste 4, Rehoboth Beach, DE 19971-4413 Ph: (914) 714-8197 |
News Archive
Vitamin D deficiency is common and cancer risk is higher among those individuals with low vitamin D levels, according to an analysis of research which will be presented at a symposium by Donald L.
EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, announced today the publication of 10-year outcome data showing that PROSTASCINT(R) (capromab pendetide) fusion imaging is an effective tool for targeting and guiding the dosing of prostate cancer radiotherapy.
Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that the European Commission, acting on the positive recommendation from the European Medicines Agency Committee for Orphan Medicinal Products (COMP), has granted orphan drug designation to synthetic hypericin (the active pharmaceutical ingredient in SGX301) for the treatment of cutaneous T-cell lymphoma (CTCL), a rare disease and a class of non-Hodgkin's lymphoma, a type of cancer of the white blood cells that are an integral part of the immune system.
A team of neurobiologists at the Institut de Neurosciences de la Timone (CNRS/Aix-Marseille Université) has just shown that within a population of rats it can predict which will become cocaine addicts.
› Verified 5 days ago
Dorsa Seimaa, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 5 Dodds Ln, Rehoboth Beach, DE 19971 Phone: 410-800-2169 | |
Dr. Duane Doyle Shubert, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 153 Beaver Dam Reach, The Woods At Seaside, Rehoboth Beach, DE 19971 Phone: 302-227-7399 Fax: 302-227-7398 | |
Dr. Melody Ann Benson, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 19878 Hebron Rd Ste 1, Rehoboth Beach, DE 19971 Phone: 302-381-8460 Fax: 302-212-2472 | |
Xiaojing Shi, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 19409 Plantation Rd Ste 4, Rehoboth Beach, DE 19971 Phone: 302-224-1400 |